SAN ANTONIO – Myriad Genetics this week presented the complete validation data for an 86 SNP breast cancer risk score that it believes can help inform the care of the large proportion of women who lack mutations in well-known cancer-linked genes.
SAN ANTONIO – Myriad Genetics this week presented the complete validation data for an 86 SNP breast cancer risk score that it believes can help inform the care of the large proportion of women who lack mutations in well-known cancer-linked genes.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.